DexCom Inc (DXCM): Kapitalisasi marang pendapatan
DexCom, Inc. (DXCM) has transformed diabetes therapy by integrating its sensors with external pumps. Global demand ensures a steady flow of funds for R&D development. The current P/S multiple, with a present value of 5.90, illustrates the resilience of the capitalization relative to revenue growth rates. High margins are sustained through automated production and the regular replacement of sensors by patients.
Rincian analitis perusahaan Dexcom Corp (DXCM)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal DexCom, Inc.|DXCM - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Dexcom CGM|DXCM - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Dexcom Corp|DXCM - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Dexcom|Rasio jangkoan perantara dexcom.com
- data bathi lan kelipatan valuasi:
DXCM - Bathi resik|Bathi resik sing dikarepake DexCom, Inc.|DXCM - Rasio rega marang bathi|Pangali forward rega marang bathi DexCom Inc|DXCM - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Dexcom Corp|DXCM - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Dexcom|DXCM - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan dexcom.com|DXCM - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep DexCom, Inc.
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:DXCM dexcom.com
DexCom, Inc. (DXCM) represents a non-cyclical business in the critical medical equipment sector, which ensures high revenue resilience against macroeconomic shocks. An analysis of historical P/S allows for the valuation of each unit of sales and identifies a defensive discount when quotes deviate from long-term averages, confirming the company's fundamental reliability through the stability of its cash flows.
Pesaing DexCom, Inc.
PEN (penumbrainc.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Novanta NOVT|HAE - Kapitalisasi marang pendapatan|Inspire Sleep - Multiplikator P/S|Rega marang dodolan Procept|CNMD: Multiplikator P/S|Rasio kapitalisasi marang pendapatan PLSE|INMD (InMode) - Multiplikator P/S|Picard Medical Corp (PMI) - Koefisien rega marang pendapatan|Multiplikator P/S SRDX|Kapitalisasi marang pendapatan Eversense SENS|Multiplikator P/S NPCE (NeuroPace, Inc.)|Multiplikator P/S Tactile Systems Technology, Inc. TCMD|SNWV - Rasio rega marang pendapatan|OM: Rasio rega marang pendapatan|ELMD (smartvest.com) - Kapitalisasi marang pendapatan|LENSAR Inc - Rasio kapitalisasi pasar marang pendapatan|RCEL (AVITA Medical, Inc.) - Multiplikator P/S|Rega marang dodolan Profound Medical Corporation PROF|Rasio rega marang pendapatan Baird Medical Investment (BDMD)|edap-tms.com (EDAP) - Multiplikator rega marang pendapatan|Apyx Medical Corporation - Kapitalisasi marang pendapatan|Multiplikator P/S IceCure Medical Ltd. ICCM|Pulmonx Corp. - Multiplikator P/S|Koefisien rega marang pendapatan TELA Bio, Inc. TELA|cytosorbents.com (CTSO) - Rasio rega marang pendapatan|Rasio rega marang dodolan SRTS (Sensus Healthcare Inc)|Rasio rega marang pendapatan Zynex Inc|Kapitalisasi marang pendapatan electroCore Medical (ECOR)|Multiplikator P/S RBOT|IINN - Rega marang dodolan|Rasio rega marang pendapatan SeaStar Medical ICU|IRIX: Rasio kapitalisasi marang pendapatan|INBS: Kapitalisasi marang pendapatan|Beyond Air, Inc. - Kapitalisasi marang volume dodolan|PFSA: Multiplikator P/S|Rasio kapitalisasi marang pendapatan SSKN|GCTK (GlucoTrack, Inc.) - Multiplikator P/S|Rega marang dodolan nanovibronix.com NAOV|Kapitalisasi marang pendapatan VERO (Venus Concept Corp)|Nuwellis Corp - Rasio kapitalisasi marang pendapatan|Multiplikator P/S AEMD (Aethlon Medical)|ASXC - Kapitalisasi marang pendapatan|AVGR - Rasio rega marang pendapatan|Rega marang dodolan BioSig|Cutera, Inc (CUTR) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan Know Labs Corporation|Kapitalisasi marang pendapatan NARI|NVRO: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S RSLS|Koefisien rega marang pendapatan Silk Road Medical, Inc.
